ProtAb For Profit
ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways.
Founded Date:
1905-06-27
Investor Type:
For Profit
Employee Number:
Jerusalem, Yerushalayim, Israel
Funding Status:
Early Stage Venture
Technology:
Biomarker panels
Last Funding Type:
Venture - Series Unknown
Investors Number:
1
Industry:
Clinical Data Management
Headquarters:
Jerusalem, Yerushalayim, Israel
Estimated Revenue:
Less than $1M